
Science News in Review: Oct. 1
Molnupiravir, an antiviral SARS-CoV-2 medication, may be linked to SARS-CoV-2 mutations Molnupiravir is an antiviral medication from Merck that has been used extensively during the SARS-CoV-2 pandemic. New findings by a group of scientists in the United …